Please use this identifier to cite or link to this item:
Title: SEOM clinical guidelines for anaplastic gliomas (2017).
Authors: Balañá, C
Alonso, M
Hernandez-Lain, A
Hernandez, A
Perez-Segura, P
Pineda, E
Ramos, A
Sanchez, A R
Teixidor, P
Verger, E
Benavides, M
Keywords: Anaplastic astrocytoma;Anaplastic glioma;Anaplastic oligodendroglioma
metadata.dc.subject.mesh: Brain Neoplasms
Issue Date: 20-Oct-2017
Abstract: The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors.
metadata.dc.identifier.doi: 10.1007/s12094-017-1762-7
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5785606.pdf477,22 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons